Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions. - Wikidata - awgldk - TriplyDB

Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.

Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.

http://www.wikidata.org/entity/Q39782797

about

Rituximab: mechanism of action Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted Agents Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance Mechanisms of action of therapeutic antibodies for cancer Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.Rituximab resistance.Expanding the targets available to therapeutic antibodies via novel disease-specific markers.Transcription regulator Yin-yang 1: from silence to cancer.Scientific rationale for extrapolation of biosimilar data across cancer indications: case study of CT-P10.Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy.Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.The role of cytokines in the regulation of drug disposition: extended functional pleiotropism?Rituximab: as first-line maintenance therapy following rituximab-containing therapy for follicular lymphoma.Postulated mechanisms of resistance of B-cell non-Hodgkin lymphoma to rituximab treatment regimens: strategies to overcome resistance.Rituximab: modes of action, remaining dispute and future perspective.RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma.Novel humanized anti-CD20 antibody BM-ca binds to a unique epitope and exerts stronger cellular activity than others.TGF-β-induced apoptosis of B-cell lymphoma Ramos cells through reduction of MS4A1/CD20.Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma.Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis.A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment.Drug-Free Macromolecular Therapeutics Induce Apoptosis via Calcium Influx and Mitochondrial Signaling Pathway.Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT.

P2860

Q24607358-E7CAAA9E-E411-4AE3-ABCC-38F5D51353C2 Q26764833-942B0E0D-5464-4F94-BC30-4EBC41E101F6 Q28243054-364ECCB5-AE45-42F5-953C-5C45BFE11002 Q28385366-AF6B03DD-070D-441C-AA4A-288AF66B0E48 Q34097414-19F9FC4B-A76D-4579-BD4E-7477B9826018 Q35041270-7F46DFE6-574A-4571-A3E2-67DB6A6C1CBC Q36119688-33F67826-10FC-4FED-8F72-36FA5A70813C Q36350378-741FBEA0-A758-4FF5-9718-001EB6735F9A Q36366077-49EBC546-92D6-4DEA-ABDD-6AF8F897DC04 Q36528137-E675754D-6ACB-4150-8669-0C3E49A0FACF Q37621025-ED8B87F4-8711-4D60-8EDF-DAAD28B66178 Q37836908-90E5FB4A-5908-481F-9590-1BBD1A430C8C Q37875060-7A64FE75-A6E4-4423-8476-83B1ADCFF41D Q38273851-FAD0F2DC-B16B-4B99-88E9-6CF81A97A8F4 Q38294619-C2E87912-DAF2-46D3-B795-5143383CB8AB Q38322277-8AF13289-67AC-4F1A-9C7B-884F06ED569F Q39091901-BE79CEAC-C09B-47C0-930B-7F632F90464F Q39157881-8C39C5BF-B3EA-46E4-A618-EC25A1A459E3 Q39337154-8857F8D4-0665-4238-9108-44E40D3AD904 Q39388577-B1927643-50CD-4072-AC63-932DF549A657 Q39493955-63EB39E0-76F7-4F67-8FBF-3BB04BD51D6F Q49177202-EA098597-F3E4-41FE-B0B0-7C20917635EE Q50504287-6E8A7EAB-08A1-4006-A2F5-48A23648E992 Q55447366-09DA6C9B-C63C-4945-B025-C6C900714C85

P2860

Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.

http://www.wikidata.org/entity/Q39782797

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Rituximab-mediated cell signal ...... dependent of its Fc functions.

@en

Rituximab-mediated cell signal ...... dependent of its Fc functions.

@nl

type

label

Rituximab-mediated cell signal ...... dependent of its Fc functions.

@en

Rituximab-mediated cell signal ...... dependent of its Fc functions.

@nl

prefLabel

Rituximab-mediated cell signal ...... dependent of its Fc functions.

@en

Rituximab-mediated cell signal ...... dependent of its Fc functions.

@nl

P1433

Q39782797-0D3259CF-AF3D-438E-894F-9446B0BE9548

P1476

Q39782797-3005021C-4C72-44B8-9C24-D471BF5FC4BB

P2093

Q39782797-5D7304BD-1FC0-4FEC-B606-0A02616B2051

Q39782797-66667B4C-FADD-4C3C-809C-6E9D452C4C90

Q39782797-7BCE1A0F-E60A-450E-B568-7E1B975C2DE2

Q39782797-9981F2F3-0B3E-4975-81AD-9BEA853B3C43

Q39782797-B22D8040-798A-4FEE-8BCE-E06A61D47E6F

Q39782797-D6DEC85E-DFD8-4997-8EBA-101C3151D4E7

Q39782797-E34F4BCF-00BC-4C44-8E26-AF6C70345939

Q39782797-EECD6299-11AB-48EF-9DB9-D31E11232DDC

P304

Q39782797-DA47779D-554C-4577-8693-77F7AD288AD6

P31

Q39782797-14D83738-BC67-4F64-8000-BFB9824474CC

P356

Q39782797-575FA4E6-D3FF-4A4E-8A8B-BB70E88A936F

P407

Q39782797-470BCCDC-6ECB-4169-8EC4-79C7CDF08CBD

P433

Q39782797-BD561B70-B89D-4760-BB9B-0F9BE023715C

P478

Q39782797-F508EE63-14AC-4345-B6CE-4261068EB845

P50

Q39782797-2BA01EF6-48B0-456A-B504-29C5E7B9B33F

Q39782797-E4B6231A-D6D0-4885-8AF4-59A1794E06BE

Q39782797-FC5F1CC0-DE57-4386-8653-742FBCB9DF10

P577

Q39782797-AC17BA60-D33B-4FA1-B48D-784A86175C41

P698

Q39782797-0394C71F-5CFA-4270-8D23-E89CE3F7FA7C

P356

1078-0432.CCR-09-1234

P1433

Clinical Cancer Research

P1476

Rituximab-mediated cell signal ...... ndependent of its Fc functions

@en

P2093

Ali R Jazirehi

http://www.w3.org/2001/XMLSchema#string

Benjamin Bonavida

http://www.w3.org/2001/XMLSchema#string

Bernardo Martinez-Miguel

http://www.w3.org/2001/XMLSchema#string

Kandasamy Hariharan

http://www.w3.org/2001/XMLSchema#string

Melisa Martinez-Paniagua

http://www.w3.org/2001/XMLSchema#string

Nabil Hanna

http://www.w3.org/2001/XMLSchema#string

Paul Chinn

http://www.w3.org/2001/XMLSchema#string

Sara Huerta-Yepez

http://www.w3.org/2001/XMLSchema#string

P304

6582-6594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-1234

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Rogelio Hernández-Pando

P577

2009-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19861448

http://www.w3.org/2001/XMLSchema#string